Alpha9 nicotinic acetylcholine receptors and the treatment of pain
Open Access
- 1 October 2009
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 78 (7) , 693-702
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Descending control of nociception: Specificity, recruitment and plasticityBrain Research Reviews, 2009
- Mammalian Nicotinic Acetylcholine Receptors: From Structure to FunctionPhysiological Reviews, 2009
- Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapseNeuropsychopharmacology, 2008
- Tracking Cell Surface GABAB Receptors Using an α-Bungarotoxin TagJournal of Biological Chemistry, 2008
- Acetylcholine beyond neurons: the non‐neuronal cholinergic system in humansBritish Journal of Pharmacology, 2008
- α-RgIA, a Novel Conotoxin That Blocks the α9α10 nAChR: Structure and Identification of Key Receptor-Binding ResiduesJournal of Molecular Biology, 2008
- Central role of α9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelializationExperimental Cell Research, 2007
- Alternative splicing controls G protein–dependent inhibition of N-type calcium channels in nociceptorsNature Neuroscience, 2007
- Molecular mechanism for analgesia involving specific antagonism of α9α10 nicotinic acetylcholine receptorsProceedings of the National Academy of Sciences, 2006
- Differential Compartmentalization and Distinct Functions of GABAB Receptor VariantsNeuron, 2006